Detection of colistin resistance gene mcr-1 in hypervirulent Klebsiella pneumoniae and Escherichia coli isolates from an infant with diarrhea in China

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 8, 2016, Pages 5099-5100

  Gu, Dan Xia ^a   Huang, Yong Lu ^a   Ma, Ji Hua ^a   Zhou, Hong Wei ^a   Fang, Ying ^a   Cai, Jia Chang ^a   Hu, Yan Yan ^a   Zhang, Rong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; ESCHERICHIA COLI PROTEIN; MCR-1 PROTEIN, E COLI;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL VIRULENCE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BRONCHITIS; CASE REPORT; CHINA; DISEASE DURATION; DYSENTERY; ENTERITIS; ESCHERICHIA COLI; GENE; HOSPITALIZATION; HUMAN; INFANT; INFANT DISEASE; INFECTIOUS DIARRHEA; INTUSSUSCEPTION; KLEBSIELLA PNEUMONIAE; LETTER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MCR 1 GENE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; DIARRHEA; DRUG EFFECTS; ENZYMOLOGY; FECES; GENETICS; MICROBIOLOGY; PATHOGENICITY; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CHINA; COLISTIN; DIARRHEA; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FECES; HUMANS; INFANT; KLEBSIELLA PNEUMONIAE; TREATMENT OUTCOME;

EID: 84979519938     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00476-16     Document Type: Letter

References (15)

1. Biswas S, Brunel JM, Dubus JC, Reynaud-Gaubert M, Rolain JM. 2012. Colistin: an update on the antibiotic of the 21st century. Expert Rev Anti Infect Ther 10:917-934. http://dx.doi.org/10.1586/eri.12.78.
2. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, Laxminarayan R. 2014. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis 14:742-750. http://dx.doi.org/10.1016/S1473-3099(14)70780-7.
3. Bradford PA, Kazmierczak KM, Biedenbach DJ, Wise MG, Hackel M, Sahm DF. 2015. Correlation of beta-Lactamase production and colistin resistance among Enterobacteriaceae isolates from a global surveillance program. Antimicrob Agents Chemother 60:1385-1392.
4. Olaitan AO, Morand S, Rolain JM. 2014. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol 5:643. http://dx.doi.org/10.3389/fmicb.2014.00643.
5. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, Yu LF, Gu D, Ren H, Chen X, Lv L, He D, Zhou H, Liang Z, Liu JH, Shen J. 2016. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161-168. http://dx.doi.org/10.1016/S1473-3099(15)00424-7.
6. Hasman H, Hammerum AM, Hansen F, Hendriksen RS, Olesen B, Agerso Y, Zankari E, Leekitcharoenphon P, Stegger M, Kaas RS, Cavaco LM, Hansen DS, Aarestrup FM, Skov RL. 2015. Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill 20(49). http://dx.doi.org/10.2807/1560-7917.ES.2015.20.49.30085.
7. Hu Y, Liu F, Lin IY, Gao GF, Zhu B. 2016. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 16:146-147. http://dx.doi.org/10.1016/S1473-3099(15)00533-2.
8. Olaitan AO, Chabou S, Okdah L, Morand S, Rolain JM. 2016. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 16:147. http://dx.doi.org/10.1016/S1473-3099(15)00540-X.
9. CLSI. 2015. Performance standards for antimicrobial susceptibility testing; 25th informational supplement. CLSI document M100-S25. Clinical and Laboratory Standards Institute, Wayne, PA.
10. EUCAST. 2016. Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0. The European Committee on Antimicrobial Susceptibility Testing. http://www.eucast.org.
11. Pomakova DK, Hsiao CB, Beanan JM, Olson R, MacDonald U, Keynan Y, Russo TA. 2012. Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumoniae: an emerging and underrecognized pathogenic variant. Eur J Clin Microbiol Infect Dis 31:981-989. http://dx.doi.org/10.1007/s10096-011-1396-6.
12. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10:597-602. http://dx.doi.org/10.1016/S1473-3099(10)70143-2.
13. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 43:4178-4182. http://dx.doi.org/10.1128/JCM.43.8.4178-4182.2005.
14. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR, Maiden MC, Ochman H, Achtman M. 2006. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 60:1136-1151. http://dx.doi.org/10.1111/j.1365-2958.2006.05172.x.
15. Siu LK, Yeh K-M, Lin J-C, Fung C-P, Chang F-Y. 2012. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis 12:881-887. http://dx.doi.org/10.1016/S1473-3099(12)70205-0.